125 related articles for article (PubMed ID: 15138583)
1. Histone deacetylase inhibitor 4-phenylbutyrate suppresses GAPDH mRNA expression in glioma cells.
Appelskog IB; Ammerpohl O; Svechnikova IG; Lui WO; Almqvist PM; Ekström TJ
Int J Oncol; 2004 Jun; 24(6):1419-25. PubMed ID: 15138583
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
Chung YL; Lee MY; Pui NN
Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin.
Svechnikova I; Almqvist PM; Ekström TJ
Int J Oncol; 2008 Apr; 32(4):821-7. PubMed ID: 18360709
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate.
Svechnikova I; Gray SG; Kundrotiene J; Ponthan F; Kogner P; Ekström TJ
Int J Oncol; 2003 Mar; 22(3):579-88. PubMed ID: 12579311
[TBL] [Abstract][Full Text] [Related]
5. [Effect of phenylbutyrate, a histone deacetylase inhibitor, on differentiation and apoptosis of Kasumi-1 cells].
Hao CL; Tang KJ; Tian Z; Xing HY; Wang M; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):241-4. PubMed ID: 12859874
[TBL] [Abstract][Full Text] [Related]
6. CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells.
Gensert JM; Baranova OV; Weinstein DE; Ratan RR
Neurobiol Dis; 2007 Jun; 26(3):671-80. PubMed ID: 17481908
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons.
Kanai H; Sawa A; Chen RW; Leeds P; Chuang DM
Pharmacogenomics J; 2004; 4(5):336-44. PubMed ID: 15289798
[TBL] [Abstract][Full Text] [Related]
8. Non-viral delivery of the connexin 43 gene with histone deacetylase inhibitor to human nasopharyngeal tumor cells enhances gene expression and inhibits in vivo tumor growth.
Hattori Y; Fukushima M; Maitani Y
Int J Oncol; 2007 Jun; 30(6):1427-39. PubMed ID: 17487363
[TBL] [Abstract][Full Text] [Related]
9. AN-113, a novel prodrug of 4-phenylbutyrate with increased anti-neoplastic activity in glioma cell lines.
Entin-Meer M; Rephaeli A; Yang X; Nudelman A; Nudelman A; Haas-Kogan DA
Cancer Lett; 2007 Aug; 253(2):205-14. PubMed ID: 17346876
[TBL] [Abstract][Full Text] [Related]
10. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells.
Kim B; Rincón Castro LM; Jawed S; Niles LP
Eur J Pharmacol; 2008 Jul; 589(1-3):45-8. PubMed ID: 18550052
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor 4-phenylbutyrate modulates glial fibrillary acidic protein and connexin 43 expression, and enhances gap-junction communication, in human glioblastoma cells.
Asklund T; Appelskog IB; Ammerpohl O; Ekström TJ; Almqvist PM
Eur J Cancer; 2004 May; 40(7):1073-81. PubMed ID: 15093585
[TBL] [Abstract][Full Text] [Related]
12. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells.
Khaw AK; Silasudjana M; Banerjee B; Suzuki M; Baskar R; Hande MP
Mutat Res; 2007 Dec; 625(1-2):134-44. PubMed ID: 17669439
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O
Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
[TBL] [Abstract][Full Text] [Related]
15. The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells.
de Ruijter AJ; Kemp S; Kramer G; Meinsma RJ; Kaufmann JO; Caron HN; van Kuilenburg AB
Biochem Pharmacol; 2004 Oct; 68(7):1279-88. PubMed ID: 15345317
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells.
Morita K; Gotohda T; Arimochi H; Lee MS; Her S
J Neurosci Res; 2009 Aug; 87(11):2608-14. PubMed ID: 19360904
[TBL] [Abstract][Full Text] [Related]
17. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
Ahn MY; Jung JH; Na YJ; Kim HS
Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664
[TBL] [Abstract][Full Text] [Related]
18. HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells.
Ammerpohl O; Thormeyer D; Khan Z; Appelskog IB; Gojkovic Z; Almqvist PM; Ekström TJ
Biochem Biophys Res Commun; 2004 Nov; 324(1):8-14. PubMed ID: 15464975
[TBL] [Abstract][Full Text] [Related]
19. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
Verheul HM; Qian DZ; Carducci MA; Pili R
Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
[TBL] [Abstract][Full Text] [Related]
20. Modulation of caspase-independent cell death leads to resensitization of imatinib mesylate-resistant cells.
Lavallard VJ; Pradelli LA; Paul A; Bénéteau M; Jacquel A; Auberger P; Ricci JE
Cancer Res; 2009 Apr; 69(7):3013-20. PubMed ID: 19318579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
